DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0028860 | Oculocerebrorenal Syndrome | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0025202 | melanoma | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0030567 | Parkinson Disease | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0003467 | Anxiety | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0024623 | Malignant neoplasm of stomach | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0017636 | Glioblastoma | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0028738 | Nystagmus | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0003850 | Arteriosclerosis | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0344315 | Depressed mood | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C2239176 | Liver carcinoma | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0949664 | Tauopathies | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0025958 | Microcephaly | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0029124 | Optic Atrophy | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0011581 | Depressive disorder | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0027651 | Neoplasms | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0011570 | Mental Depression | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0699791 | Stomach Carcinoma | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0036439 | Scoliosis, unspecified | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0003469 | Anxiety Disorders | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0520947 | Clumsiness - motor delay | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0497327 | Dementia | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0005684 | Malignant neoplasm of urinary bladder | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0026850 | Muscular Dystrophy | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0241005 | Creatine phosphokinase serum increased | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0011265 | Presenile dementia | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024